[BCT] YoY Quarter Result on 31-Jan-2022 [#Q2]

Stock
[BCT] BriaCell Therapeutics Corp.
Announcement Date
30-Jan-2022
Financial Year
2022
Quarter
31-Jan-2022 [#Q2]
Profit Trend
QoQ- 146.80%
YoY- 1,121.67%
Quarter Report
BCT's Result
BCT's Financial Summary
View:
Show?
Quarter Result
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,334 -11,882 2,199 180 501 -1,205 -792 55.78%
Tax 1,447 15,031 12 -44 -0 166 -0 -
NP -11,295 -26,913 2,199 180 501 -1,205 -792 55.69%
Tax Rate - - -0.55% 24.44% 0.05% - - -
Total Cost 11,295 26,913 -2,199 -180 -501 1,205 792 55.69%
Ratio Analysis
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/01/24 31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 CAGR
EPS -0.71 -1.73 0.71 0.03 0.69 -2.21 -2.12 -16.65%
EPS Diluted -0.71 -1.73 0.71 0.03 0.69 -2.21 -2.12 -16.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.